These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38202101)

  • 21. Does moderate hyperkalemia influence survival in HF? Insights from the MECKI score data base.
    Toto F; Salvioni E; Magrì D; Sciomer S; Piepoli M; Badagliacca R; Galotta A; Baracchini N; Paolillo S; Corrà U; Raimondo R; Lagioia R; Filardi PP; Iorio A; Senni M; Correale M; Cicoira M; Perna E; Metra M; Guazzi M; Limongelli G; Sinagra G; Parati G; Cattadori G; Bandera F; Bussotti M; Mapelli M; Cipriani M; Bonomi A; Cunha G; Re F; Vignati C; Garascia A; Lombardi C; Scardovi AB; Passantino A; Emdin M; Passino C; Santolamazza C; Girola D; Zaffalon D; Vizza D; De Martino F; Agostoni P;
    Int J Cardiol; 2023 Jan; 371():273-277. PubMed ID: 36115445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct Current Cardioversion in Atrial Fibrillation Patients on Edoxaban Therapy Versus Vitamin K Antagonists: a Real-world Propensity Score-Matched Study.
    Rago A; Papa AA; Attena E; Parisi V; Golino P; Nigro G; Russo V
    Cardiovasc Drugs Ther; 2021 Oct; 35(5):1003-1007. PubMed ID: 32946035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical profile of direct oral anticoagulants versus vitamin K anticoagulants in octogenarians with atrial fibrillation: a multicentre propensity score matched real-world cohort study.
    Russo V; Attena E; Di Maio M; Mazzone C; Carbone A; Parisi V; Rago A; D'Onofrio A; Golino P; Nigro G
    J Thromb Thrombolysis; 2020 Jan; 49(1):42-53. PubMed ID: 31385163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Benefit of Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves.
    Russo V; Carbone A; Attena E; Rago A; Mazzone C; Proietti R; Parisi V; Scotti A; Nigro G; Golino P; D'Onofrio A
    Clin Ther; 2019 Dec; 41(12):2549-2557. PubMed ID: 31735436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical outcomes in patients receiving edoxaban or phenprocoumon for prevention of stroke in atrial fibrillation: a German real-world cohort study.
    Hohmann C; Lutz M; Vignali S; Borchert K; Seidel K; Braun S; Baldus S; Näbauer M
    Thromb J; 2022 Jul; 20(1):37. PubMed ID: 35787710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of fracture in patients with non-valvular atrial fibrillation initiating direct oral anticoagulants vs. vitamin K antagonists.
    He N; Dell'Aniello S; Zhai S; Suissa S; Renoux C
    Eur Heart J Cardiovasc Pharmacother; 2021 Sep; 7(5):389-397. PubMed ID: 32722764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of prognostic impact of anticoagulants in heart failure patients with atrial fibrillation and renal dysfunction: direct oral anticoagulants versus vitamin K antagonists.
    Sakai T; Motoki H; Fuchida A; Takeuchi T; Otagiri K; Kanai M; Kimura K; Minamisawa M; Yoshie K; Saigusa T; Ebisawa S; Okada A; Kitabayashi H; Kuwahara K
    Heart Vessels; 2022 Jul; 37(7):1232-1241. PubMed ID: 35064298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased serum uric acid level predicts poor prognosis in mildly severe chronic heart failure with reduced ejection fraction. An analysis from the MECKI score research group.
    Piepoli MF; Salvioni E; Corrà U; Doni F; Bonomi A; La Gioia R; Limongelli G; Paolillo S; Sinagra G; Scardovi AB; Raimondo R; Emdin M; Re F; Cicoira M; Correale M; Badagliacca R; Clemenza F; Lombardi C; Agostoni P
    Eur J Intern Med; 2020 Feb; 72():47-52. PubMed ID: 31787490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Old and new equations for maximal heart rate prediction in patients with heart failure and reduced ejection fraction on beta-blockers treatment: results from the MECKI score data set.
    Magrì D; Piepoli M; Gallo G; Corrà U; Metra M; Paolillo S; Filardi PP; Maruotti A; Salvioni E; Mapelli M; Vignati C; Senni M; Limongelli G; Lagioia R; Scrutinio D; Emdin M; Passino C; Parati G; Sinagra G; Correale M; Badagliacca R; Sciomer S; Di Lenarda A; Agostoni P
    Eur J Prev Cardiol; 2022 Sep; 29(12):1680-1688. PubMed ID: 35578814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of edoxaban compared with warfarin in patients with atrial fibrillation and heart failure: insights from ENGAGE AF-TIMI 48.
    Magnani G; Giugliano RP; Ruff CT; Murphy SA; Nordio F; Metra M; Moccetti T; Mitrovic V; Shi M; Mercuri M; Antman EM; Braunwald E
    Eur J Heart Fail; 2016 Sep; 18(9):1153-61. PubMed ID: 27349698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and heart failure.
    Martinez BK; Bunz TJ; Eriksson D; Meinecke AK; Sood NA; Coleman CI
    ESC Heart Fail; 2019 Feb; 6(1):10-15. PubMed ID: 30299591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term prognostic role of diabetes mellitus and glycemic control in heart failure patients with reduced ejection fraction: Insights from the MECKI Score database.
    Paolillo S; Salvioni E; Perrone Filardi P; Bonomi A; Sinagra G; Gentile P; Gargiulo P; Scoccia A; Cosentino N; Gugliandolo P; Badagliacca R; Lagioia R; Correale M; Frigerio M; Perna E; Piepoli M; Re F; Raimondo R; Minà C; Clemenza F; Bussotti M; Limongelli G; Gravino R; Passantino A; Magrì D; Parati G; Caravita S; Scardovi AB; Arcari L; Vignati C; Mapelli M; Cattadori G; Cavaliere C; Corrà U; Agostoni P;
    Int J Cardiol; 2020 Oct; 317():103-110. PubMed ID: 32360652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A rapid evidence assessment of bleed-related healthcare resource utilization in publications reporting the use of direct oral anticoagulants for non-valvular atrial fibrillation.
    Shah BR; Scholtus E; Rolland C; Batscheider A; Katz JN; Nilsson KR
    Curr Med Res Opin; 2019 Jan; 35(1):127-139. PubMed ID: 30380959
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparative Effectiveness and Safety of Apixaban and Vitamin K Antagonist Therapy in Patients With Nonvalvular Atrial Fibrillation Treated in Routine German Practice.
    Coleman CI; Peacock WF; Antz M
    Heart Lung Circ; 2018 Mar; 27(3):390-393. PubMed ID: 28528780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Edoxaban versus warfarin in vitamin K antagonist experienced and naïve patients from the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomised trial.
    Kozieł M; Al-Saady N; Hjortshøj SP; Goudev A; Huber K; Cohen A; Jin J; Melino M; Winters SM; Goette A; Lip GYH
    Clin Res Cardiol; 2020 Aug; 109(8):1018-1024. PubMed ID: 31915996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct Oral Anticoagulant (DOAC) Dosing in Patients with Non-valvular Atrial Fibrillation (NVAF) in the United Kingdom: A Retrospective Cohort Study Using CPRD Gold Database.
    Khachatryan A; Doobaree IU; Spentzouris G; Gusto G; Zawaneh Y; Mughal F; Anastassopoulou A; Manu M; Fay M
    Adv Ther; 2023 Feb; 40(2):504-520. PubMed ID: 36399317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation.
    Mostaza JM; Suarez C; Cepeda JM; Manzano L; Sánchez D;
    BMC Cardiovasc Disord; 2021 Aug; 21(1):384. PubMed ID: 34372782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term vitamin K antagonists treatment patterns of Non-Valvular Atrial Fibrillation (NVAF): a population-based cohort study.
    Renoux C; Coulombe J; Suissa S
    BMC Cardiovasc Disord; 2016 May; 16():84. PubMed ID: 27160254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Better clinical outcome with direct oral anticoagulants in hospitalized heart failure patients with atrial fibrillation.
    Yoshihisa A; Sato Y; Sato T; Suzuki S; Oikawa M; Takeishi Y
    BMC Cardiovasc Disord; 2018 Jan; 18(1):11. PubMed ID: 29368593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness and Safety of Four Direct Oral Anticoagulants in Asian Patients With Nonvalvular Atrial Fibrillation.
    Chan YH; Lee HF; See LC; Tu HT; Chao TF; Yeh YH; Wu LS; Kuo CT; Chang SH; Lip GYH
    Chest; 2019 Sep; 156(3):529-543. PubMed ID: 31103697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.